BCDA logo

BioCardia (BCDA) Company Overview

Profile

Full Name:

BioCardia, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

November 13, 1996

Indexes:

Not included

Description:

BioCardia (BCDA) focuses on developing innovative cell-based therapies for heart diseases. The company aims to improve patient outcomes through advanced regenerative medicine, utilizing its proprietary technology to deliver cardiac stem cells directly to the heart, enhancing recovery and function in patients with heart conditions.

Key Details

Price

$2.54

Annual Revenue

$477.00 K(-64.72% YoY)

Annual EPS

-$8.25(+17.91% YoY)

Annual ROE

-703.62%

Beta

0.88

Events Calendar

Earnings

Next earnings date:

Mar 27, 2025

Recent quarterly earnings:

Nov 13, 2024

Recent annual earnings:

Mar 27, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

May 30, 2024

Analyst ratings

Recent major analysts updates

Dec 18, 24 HC Wainwright & Co.
Buy
Nov 14, 24 HC Wainwright & Co.
Buy
Oct 28, 24 HC Wainwright & Co.
Buy
Aug 21, 24 HC Wainwright & Co.
Buy
Aug 16, 24 HC Wainwright & Co.
Buy
Jul 26, 24 HC Wainwright & Co.
Buy
May 29, 24 HC Wainwright & Co.
Buy
Nov 14, 23 HC Wainwright & Co.
Buy
Oct 11, 23 HC Wainwright & Co.
Buy
Sep 6, 23 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for BioCardia?
  • Does BioCardia pay dividends?
  • What sector is BioCardia in?
  • What industry is BioCardia in?
  • What country is BioCardia based in?
  • When did BioCardia go public?
  • Is BioCardia in the S&P 500?
  • Is BioCardia in the NASDAQ 100?
  • Is BioCardia in the Dow Jones?
  • When was BioCardia's last earnings report?
  • When does BioCardia report earnings?
  • Should I buy BioCardia stock now?

What is the ticker symbol for BioCardia?

The ticker symbol for BioCardia is NASDAQ:BCDA

Does BioCardia pay dividends?

No, BioCardia does not pay dividends

What sector is BioCardia in?

BioCardia is in the Healthcare sector

What industry is BioCardia in?

BioCardia is in the Biotechnology industry

What country is BioCardia based in?

BioCardia is headquartered in United States

When did BioCardia go public?

BioCardia's initial public offering (IPO) was on November 13, 1996

Is BioCardia in the S&P 500?

No, BioCardia is not included in the S&P 500 index

Is BioCardia in the NASDAQ 100?

No, BioCardia is not included in the NASDAQ 100 index

Is BioCardia in the Dow Jones?

No, BioCardia is not included in the Dow Jones index

When was BioCardia's last earnings report?

BioCardia's most recent earnings report was on Nov 13, 2024

When does BioCardia report earnings?

The next expected earnings date for BioCardia is Mar 27, 2025

Should I buy BioCardia stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions